Apr 28, 2023 The UK voluntary scheme for branded medicines pricing and access (VPAS): just what the doctor ordered, or a bitter pill to swallow? By Michael Stead Martha Pownall On the 1 April this year, amidst storm clouds gathering above the NHS in the form of staffing strikes, record waiting times and chronic...
Apr 25, 2023 The Czech government is planning a regulated cannabis market By Jan Metelka Dylan Kennett The Czech government has announced its plan to introduce a highly regulated cannabis market in the Czech Republic. Currently, cannabis is...
Apr 20, 2023 Cross-border considerations for privacy in clinical trials - At the Intersection of Sciences and Law Podcast Series By James Clark Paula Gonzalez de Castejón Llano-Ponte David Kopans In this episode of At the Intersection of Sciences and Law Podcast Series, in light of the recent publication of our Cross-border Guide...
Apr 17, 2023 Plausibility of inventions: the decision of the EPO Enlarged Board of Appeal in G 2/21 By Massimiliano Tiberio Introduction On March 23rd, 2023, the Enlarged Board of Appeal of the EPO issued the long-awaited decision concerning the concept of...
Apr 12, 2023 The New Italian Public Contracts Code By Giorgia Romitelli Roberta Moffa Anna Mazzoncini Riccardo Scioscia +1 more... Show less As of March 28, The Italian Council of Ministers have approved the new Public Contracts Code. The Legislative Decree No. 36 of March 31,...
Apr 11, 2023 Italy modifies medical device payback system for 2015-2018: Companies have to make quick and important choices By Giorgia Romitelli Giovanni Iaselli Roberta Moffa With Law Decree no. 34/2023, the Italian government has approved significant changes to the Italian medical devices payback system for...
Apr 03, 2023 New Guidance from the Medicines & Healthcare products Regulatory Agency (MHRA) on the Intended Purpose Statement for Medical Device Software By Poppy Williams As part of the MHRA’s Software and AI as a Medical Device Change Programme, the MHRA has recently published guidance on crafting an...
Mar 20, 2023 Extended transition period gives medical device industry extra time to comply with EU MDR By Marco de Morpurgo Nicola Landolfi A much-awaited extension of the MDR transition period became effective today with the publication of Regulation (EU) 2023/607 in the...
Mar 10, 2023 Poland - Life Sciences monthly brief, February 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Medicinal productsClinical...
Feb 09, 2023 Portugal: A transformation of the healthcare system may be under way By Mariana Ricardo Pharmacies have always played a relevant role in healthcare in Portugal, where pharmacists and pharmacy technicians traditionally share...
Feb 06, 2023 Poland - Life Sciences Monthly Brief, January 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Pharmacies; Clinical...
Feb 01, 2023 Working on the affordability of medicines: 2023 begins with an important message on excessive pricing - Portugal By Mariana Ricardo Early this year, the Portuguese Minister of Health stated the public expense with medicines in 2022 showed an increase of more than EUR...
Jan 23, 2023 Pharmaceutical and medical sector in Poland, DLA Piper Report By Andrzej Balicki, Ph.D. Jolanta Dabrowicz We would like to invite you to read our report summarising the second edition of the DLA Piper survey "Pharmaceutical and medical sector...
Nov 15, 2022 Clinical Trials and Privacy Matters: A Cross-border Guide By Marco de Morpurgo This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...
Sep 23, 2022 Interchangeability of biosimilar medicines confirmed by EMA and HMA By Mariana Ricardo The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) issued a joint statement on the interchangeability of...
Jul 14, 2022 UK: New National Strategy for Health Data By James Clark The UK’s Department for Health and Social Care (“DHSC”) has published a major strategy document (‘Data saves lives: reshaping health and...